STEM CELL MOBILIZATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA FOLLOWING THERAPY WITH LENALIDOMIDE AND DEXAMETHASONE

被引：0
|
作者：
Kumar, S. [1 ]
Lacy, M. Q. [1 ]
Dispenzieri, A. [1 ]
Hayman, S. R. [1 ]
Dingli, D. [1 ]
Miceli, T. [1 ]
Litzow, M. R. [1 ]
Rajkumar, S. V. [1 ]
Gertz, M. A. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.205
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
177
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [1] Stem Cell Mobilization Following Initial Therapy with Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
    Kumar, Shaji
    Lacy, Martha
    Dispenzieri, Angela
    Hayman, Suzzanne
    Buadi, Francis
    Dingli, David
    Miceli, Teresa
    Litzow, Mark
    Rajkumar, S. Vincent
    Gertz, Morie
    [J]. BLOOD, 2008, 112 (11) : 1189 - 1189
  • [2] Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy
    F Cavallo
    S Bringhen
    G Milone
    D Ben-Yehuda
    A Nagler
    E Calabrese
    N Cascavilla
    V Montefusco
    B Lupo
    A M Liberati
    C Crippa
    F Rossini
    R Passera
    F Patriarca
    A M Cafro
    P Omedè
    A M Carella
    J Peccatori
    L Catalano
    T Caravita
    P Musto
    M T Petrucci
    M Boccadoro
    A Palumbo
    [J]. Leukemia, 2011, 25 : 1627 - 1631
  • [3] Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy
    Cavallo, F.
    Bringhen, S.
    Milone, G.
    Ben-Yehuda, D.
    Nagler, A.
    Calabrese, E.
    Cascavilla, N.
    Montefusco, V.
    Lupo, B.
    Liberati, A. M.
    Crippa, C.
    Rossini, F.
    Passera, R.
    Patriarca, F.
    Cafro, A. M.
    Omede, P.
    Carella, A. M.
    Peccatori, J.
    Catalano, L.
    Caravita, T.
    Musto, P.
    Petrucci, M. T.
    Boccadoro, M.
    Palumbo, A.
    [J]. LEUKEMIA, 2011, 25 (10) : 1627 - 1631
  • [4] Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma
    Ria, Roberto
    Reale, Antonia
    Solimando, Antonio Giovanni
    Mangialardi, Giuseppe
    Moschetta, Michele
    Gelao, Lucia
    Iodice, Giuseppe
    Vacca, Angelo
    [J]. STEM CELLS INTERNATIONAL, 2012, 2012
  • [5] Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
    Richardson, Paul G.
    Weller, Edie
    Lonial, Sagar
    Jakubowiak, Andrzej J.
    Jagannath, Sundar
    Raje, Noopur S.
    Avigan, David E.
    Xie, Wanling
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Mazumder, Amitabha
    Munshi, Nikhil C.
    Vesole, David H.
    Joyce, Robin
    Kaufman, Jonathan L.
    Doss, Deborah
    Warren, Diane L.
    Lunde, Laura E.
    Kaster, Sarah
    DeLaney, Carol
    Hideshima, Teru
    Mitsiades, Constantine S.
    Knight, Robert
    Esseltine, Dixie-Lee
    Anderson, Kenneth C.
    [J]. BLOOD, 2010, 116 (05) : 679 - 686
  • [6] Lenalidomide and Dexamethasone Therapy in Elderly Patients with Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide
    Kobayashi, Takahiro
    Miura, Masatomo
    Niioka, Takenori
    Fujioka, Yuki
    Abumiya, Maiko
    Yoshioka, Tomoko
    Kameoka, Yoshihiro
    Nishikawa, Hiroyoshi
    Takahashi, Naoto
    [J]. BLOOD, 2017, 130
  • [7] Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma
    Mark, Tomer M.
    Bowman, Isaac A.
    Rossi, Adriana C.
    Shah, Manan
    Rodriguez, Melissa
    Quinn, Ryann
    Pearse, Roger N.
    Zafar, Faiza
    Pekle, Karen
    Jayabalan, David
    Ely, Scott
    Coleman, Morton
    Chen-Kiang, Selina
    Niesvizky, Ruben
    [J]. LEUKEMIA & LYMPHOMA, 2014, 55 (12) : 2842 - 2849
  • [8] Daratumumab Plus Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
    Jakubowiak, Andrzej
    Usmani, Saad Z.
    Krishnan, Amrita
    Lonial, Sagar
    Comenzo, Raymond L.
    Wang, Jianping
    de Boer, Carla
    Deraedt, William
    Weiss, Brendan M.
    Schecter, Jordan M.
    Chari, Ajai
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (10): : 701 - 710
  • [9] Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
    Kumar, Shaji K.
    Kapoor, Prashant
    Laplant, Betsy
    Phuong-Dung, Liang
    Muchtar, Eli
    Buadi, Francis K.
    Gonsalves, Wilson I.
    Malave, Gabriella C.
    Vossen, Alanna M.
    Dingli, David
    Go, Ronald S.
    Warsame, Rahma M.
    Kourelis, Taxiarchis
    Hwa, Yi L.
    Fonder, Amie
    Hobbs, Miriam A.
    Lust, John A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Leung, Nelson
    Rajkumar, S. Vincent
    Gertz, Morie A.
    [J]. BLOOD, 2020, 136
  • [10] Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma
    Kumar, S.
    Dispenzieri, A.
    Lacy, M. Q.
    Hayman, S. R.
    Buadi, F. K.
    Gastineau, D. A.
    Litzow, M. R.
    Fonseca, R.
    Roy, V.
    Rajkumar, S. V.
    Gertz, M. A.
    [J]. LEUKEMIA, 2007, 21 (09) : 2035 - 2042
12345